Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. ERYTECH Pharma S.A.
  6. News
  7. Summary
    ERYP   FR0011471135

ERYTECH PHARMA S.A.

(ERYP)
  Report
Real-time Euronext Paris  -  11:15 2022-12-01 am EST
0.6240 EUR   -0.72%
11:21aEuropean Equities Move Higher Thursday as EU Nears Cap on Russian Oil
MT
11/22Transcript : ERYTECH Pharma S.A., Q3 2022 Earnings Call, Nov 22, 2022
CI
11/21ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Decline in Monday Trading

09/26/2022 | 12:05pm EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC -1.84% 2.13 Delayed Quote.-41.60%
BIONTECH SE 1.35% 169.3 Delayed Quote.-35.21%
ENDAVA PLC 1.93% 78.19 Delayed Quote.-54.32%
ERYTECH PHARMA S.A. -0.72% 0.624 Real-time Quote.-70.35%
EVAXION BIOTECH A/S 2.29% 2.23 Delayed Quote.-50.68%
HSBC HOLDINGS PLC -2.28% 498 Delayed Quote.13.61%
IDEX BIOMETRICS ASA 2.20% 1.162 Real-time Quote.-64.02%
IDEX CORPORATION 0.96% 239.9 Delayed Quote.0.50%
MATERIALISE NV -0.31% 9.62 Delayed Quote.-59.57%
MYNARIC AG -3.77% 15.3 Delayed Quote.-65.70%
NATIONAL GRID PLC 1.28% 1028 Delayed Quote.-4.27%
NATWEST GROUP PLC -1.11% 258.8 Delayed Quote.7.75%
NUCANA PLC -1.51% 0.841 Delayed Quote.-64.12%
TRIVAGO N.V. 3.24% 1.44 Delayed Quote.-36.24%
VODAFONE GROUP PLC -0.25% 91.59 Delayed Quote.-18.19%
All news about ERYTECH PHARMA S.A.
11:21aEuropean Equities Move Higher Thursday as EU Nears Cap on Russian Oil
MT
11/22Transcript : ERYTECH Pharma S.A., Q3 2022 Earnings Call, Nov 22, 2022
CI
11/21ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
GL
11/21ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
AQ
11/21ERYTECH Pharma S.A. Reports Earnings Results for the Nine Months Ended September 30, 20..
CI
11/18Pharmaceutical Stocks Help European Equities Nudge Higher to End Quiet Week
MT
11/15European Markets Move Higher Helped by Upbeat US Inflation Data
MT
11/14European ADRs Continue to Trend Higher in Monday Trading
MT
11/11European ADRs Move Slightly Lower in Friday Trading
MT
11/08European ADRs Move Higher in Tuesday Trading, Adding to Monday's Gains
MT
More news
Analyst Recommendations on ERYTECH PHARMA S.A.
More recommendations
Financials
Sales 2022 9,20 M 9,49 M 9,49 M
Net income 2022 -52,8 M -54,4 M -54,4 M
Net Debt 2022 1,50 M 1,55 M 1,55 M
P/E ratio 2022 -0,28x
Yield 2022 -
Capitalization 19,5 M 20,1 M 20,1 M
EV / Sales 2022 2,28x
EV / Sales 2023 1,45x
Nbr of Employees 149
Free-Float 98,5%
Chart ERYTECH PHARMA S.A.
Duration : Period :
ERYTECH Pharma S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ERYTECH PHARMA S.A.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus SELL
Number of Analysts 1
Last Close Price 0,63 €
Average target price 3,60 €
Spread / Average Target 473%
EPS Revisions
Managers and Directors
Gil Beyen Chief Executive Officer & Director
Eric Soyer Chief Operating & Financial Officer
Jean-Paul Kress Chairman
Iman El-Hariry Chief Medical Officer
Stewart Craig Chief Technical Officer
Sector and Competitors
1st jan.Capi. (M$)
ERYTECH PHARMA S.A.-70.35%20
VERTEX PHARMACEUTICALS44.08%81 217
REGENERON PHARMACEUTICALS, INC.16.56%80 283
BIONTECH SE-35.21%40 589
WUXI APPTEC CO., LTD.-34.22%32 137
GENMAB A/S24.30%29 594